Sovateltide is a peptide composed of 14 amino acids. The sequence contains a large number of carboxyl groups and has strong biological activity. Because of this characteristic, in the production of synthetic sovateltide, the yield is often reduced due to insufficient stability. The medicine using sovateltide as the main raw material can be used to treat acute cerebral ischemic stroke, and has now entered clinical phase 3.